CGM-Derived Glycemic Persistence Index Predicts OGTT 2-Hour Glucose in Dysglycemia
In an observational cohort study of adults with paired free-living continuous glucose monitoring (CGM) and oral glucose tolerance testing (OGTT), researchers evaluated the glycemic persistence index (GPI) as a CGM-derived metric. The primary aim was to predict OGTT 2-hour glucose, with secondary aims including day-to-day repeatability of CGM metrics and classification of OGTT-defined dysglycemia. The cohort size, setting, and follow-up duration were not reported.
For the primary outcome, GPI was the strongest single predictor of OGTT 2-hour glucose, with an LOO R^2 = 0.439. Day-to-day repeatability of GPI was strong, with an ICC = 0.665. For classifying OGTT-defined dysglycemia, HbA1c had a slightly higher AUC than GPI, but the combination of GPI plus HbA1c performed best overall, indicating complementary information.
No adverse events, serious adverse events, discontinuations, or tolerability data were reported. Key limitations include the absence of reported sample size, setting, and follow-up duration. As an observational cohort study, associations are reported, not causation, and results are based on a single cohort, so generalizability and external validity are not established.
Practice relevance is restrained: GPI may serve as a convenient CGM-derived marker of dysglycemia that could reduce reliance on burdensome OGTT, but it should not be considered a replacement for OGTT, and clinical utility beyond prediction and classification is not established.